Prof. Paul Finn presented on a major cause of failure of antibacterial drug discovery projects, failure to accumulate sufficiently at the site of action to obtain an antibacterial effect, at the 2nd SCI/RSC Symposium on Antimicrobial Drug Discovery.

Prof. Finn reviews attempts to address this issue through greater understanding the structural basis for penetration and the identification of rules for the regions of chemical property space that are compatible with antibacterial activity.

Our own work, building machine learning models based on 3D molecular representations from a ligand-based perspective, is also considered.

For more information, or a copy of Paul’s slides, please Contact Us.